Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 627.85k | - |
| Gross profit | 399.47k | - |
| Net profit | -307.19k | - |
| EBITDA | -173.97k | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €11.15m |
Number of shares | 453.88m |
52-week high/low | €0.0952 - €0.0221 |
| Dividends | No |
Beta | 1.14 |
P/E ratio | -10.00 |
PEG ratio | -0.12 |
P/B ratio | 5.59 |
P/S ratio | 12.20 |
Company profile
Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand and internationally. The company's products include hand sanitizers, textile applicators, mould remediation, and surface sanitizers. It serves airlines, healthcare, childcare, facilities management, transportation, education, and hospitality sectors. The company was incorporated in 1986 and is headquartered in Auckland, New Zealand.
| Name | ZOONO GRP LTD |
| CEO | Paul Hyslop |
| Headquarters | Auckland,
au New Zealand |
| Website | |
| IPO | 24/02/2020 |
| Employees | 2 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Australian Securities Exchange Ltd | ZNO.AX |
Pnk | ZOONF |